FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Exhibit 10.5
FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
THIS FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this "Agreement"), dated as of July _1__, 2008 is between and among ATRION CORPORATION, a Delaware corporation, ATRION MEDICAL PRODUCTS, INC., an Alabama corporation, XXXXXX-XXXXXXX CORPORATION, a Florida corporation, QUEST MEDICAL, INC., a Texas corporation, ALATENN PIPELINE COMPANY, LLC, an Alabama limited liability company, and ATRION LEASING COMPANY, LLC, an Alabama limited liability company (collectively, the "Borrowers"), and WACHOVIA BANK, NATIONAL ASSOCIATION, a national banking association (the "Lender").
R E C I T A L S:
Lender has heretofore established a Credit Facility for the Borrowers' benefit in the maximum principal sum of Twenty-Five Million Dollars ($25,000,000), which is evidenced and secured by the following:
|
|
·
|
Loan and Security Agreement dated November 12, 1999, as amended by Amendment to Loan and Security Agreement dated as of December 26, 2001, by Second Amendment to Loan and Security Agreement dated November 7, 2003, and by Third Amendment to Loan and Security Agreement dated September 1, 2005 (as amended, the "Loan Agreement"); and
|
|
|
·
|
Line of Credit Promissory Note dated November 12, 1999 in the original stated principal amount of $18,500,000, as amended by Note Extension Agreement dated August 31, 2001, by Second Amendment to Line of Credit Promissory Note dated December 26, 2001 (which such Second Amendment, among other things, increased the principal balance of the Line of Credit Note to $25,000,000), by Third Amendment to Line of Credit Promissory Note dated November 7, 2003, and by Fourth Amendment to Line of Credit Promissory Note dated September 1, 2005 (as amended, the "Line of Credit Note"), evidencing the Line of Credit Loan portion of the Credit Facility.
|
B. The Credit Facility terminates on the Termination Date of November 12, 2009, and the outstanding principal balance of all Advances, together with accrued and unpaid interest thereon, is due and payable in full on the Termination Date of November 12, 2009.
C. Borrowers have requested that the Termination Date be extended until November 12, 2012. Borrowers have further requested that the Revised Pricing Matrix which is attached as Revised Exhibit A to the Second Amendment to Loan and Security Agreement dated November 7, 2003, be modified and amended to reduce the Unused Line Fee (where applicable) from 12.5 bps (.125%) to 7.5 bps (.075%). Lender has agreed to such modifications.
D. To date, no Term Loans or Letters of Credit exist under the Credit Facility.
NOW, THEREFORE, in consideration of the premises and of the mutual covenants and agreements herein contained, Ten Dollars ($10.00) and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
Defined Terms. Capitalized terms used in this Agreement without definition shall have the meanings ascribed to them in the Loan Agreement.
Termination Date Extended. The Loan Agreement is hereby modified and amended to extend the Termination Date from November 12, 2009 until November 12, 2012 by deleting in its entirety the Defined Term "Termination Date" as the same appears in Section 1 of the Line of Note, and by inserting in lieu thereof the following:
"Termination Date" means November 12, 2012, or such earlier date on which the obligations of the Lender to make Advances hereunder are terminated pursuant to the terms of this Agreement or such subsequent date or dates to which the availability of Advances hereunder is extended pursuant to the provisions set forth in Section 2.13 hereof.
Pricing Matrix. The Revised Pricing Matrix attached as "Revised Exhibit A" to the Second Amendment to Loan and Security Agreement dated as of November 7, 2003 is hereby deleted in its entirety, and the Revised Pricing Matrix which is attached hereto as Revised Exhibit A is hereby inserted in lieu thereof and shall henceforth be deemed the applicable Pricing Matrix for the Credit Facility.
Notices. Section 8.6 is hereby modified and amended to change the address of Lender as follows:
Wachovia Bank, National Association
0000 Xxxxxxxx Xxxxx, Xxxxx 000 Xxxx
Xxxxxxx, Xxxxx 00000
Governing Law. The Loan Agreement is hereby further modified and amended to provide that the same (as modified hereby) shall be governed by, and construed in accordance with, the laws of the State of Texas.
Amendment to Line of Credit Note. Contemporaneously herewith, Borrowers and Lender have entered into that certain Fifth Amendment to Line of Credit Promissory Note pursuant to which the Termination Date set forth in the Line of Credit Note has been extended to November 12, 2012. All references in the Loan Agreement to the "Line of Credit Note" shall henceforth refer to the Line of Credit Note, as amended by the Fifth Amendment to Line of Credit Promissory Note.
Confirmation of Obligations. Except as herein modified, the Loan Agreement shall remain in full force and effect, and the Loan Agreement is hereby ratified and affirmed in all respects.
No Novation and No Release of Collateral. The execution and delivery of this Agreement shall not be interpreted or construed as, and in fact does not constitute, a novation, payment, or satisfaction of all or any portion of the Loan Agreement; rather, this Agreement is strictly amendatory in nature. The execution, delivery, and performance of this Agreement shall not operate to release any Collateral securing the Credit Facility nor modify or otherwise affect the lien and security interest held by Lender in and to such Collateral.
Counterparts. This Agreement may be executed in multiple counterparts and using multiple signature pages and shall be binding and enforceable at such time as each party has executed a counterpart of this Agreement. The signature of any party to a counterpart of this Agreement shall bind such party to the same extent as if all parties executed a single original hereof.
Interpretation. No provision of this Agreement shall be construed against or interpreted to the disadvantage of any party to this Agreement by any court or other governmental or judicial authority by reason of such party's having or being deemed to have structured or dictated such provision.
Integration. Borrowers acknowledge and agree that no promises, agreements, understandings, or commitments of any nature whatsoever have been made by or on behalf of Lender in respect to the Credit Facility and the Loan Agreement, except as set forth herein. Specifically, Borrowers acknowledge and agree that Lender has made no agreement, and is in no way obligated, to grant any extension, indulgence, forbearance, or consent with respect to the Credit Facility or any matter relating to the Credit Facility, except as specifically set forth herein.
Severability. If any provisions of this Agreement or the application thereof to any person or circumstance shall be invalid or unenforceable to any extent, the remainder of this Agreement and the application of such provisions to other persons or circumstances shall not be affected thereby and shall be enforced to the greatest extent permitted by law.
Waiver of Jury Trial. BORROWERS HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY ON ANY CLAIM, COUNTERCLAIM, SETOFF, DEMAND, ACTION OR CAUSE OF ACTION ARISING OUT OF OR IN ANY WAY PERTAINING OR RELATED TO LOAN OBLIGATION, THIS AGREEMENT, OR ANY OTHER LOAN DOCUMENT, OR IN ANY WAY CONNECTED WITH OR PERTAINING OR RELATED TO OR INCIDENTAL TO ANY DEALINGS OF LENDER AND BORROWERS WITH RESPECT TO THE LOAN OBLIGATIONS, THIS AGREEMENT, AND ANY OTHER LOAN DOCUMENT, OR IN CONNECTION WITH THE TRANSACTIONS RELATED HERETO OR CONTEMPLATED HEREBY OR THE EXERCISE OF ANY PARTY'S RIGHTS AND REMEDIES WITH RESPECT TO THE LOAN OBLIGATIONS, THIS AGREEMENT, OR OTHERWISE, OR THE CONDUCT OF THE RELATIONSHIP OF THE PARTIES HERETO, IN ALL OF THE FOREGOING CASES WHETHER NOW EXISTING OR HEREAFTER ARISING AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. BORROWERS ACKNOWLEDGE THAT LENDER MAY FILE A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY, AND BARGAINED AGREEMENT OF THE BORROWERS IRREVOCABLY TO WAIVE THEIR RIGHTS TO TRIAL BY JURY, AND THAT, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ANY DISPUTE OR CONTROVERSY WHATSOEVER BETWEEN BORROWERS AND LENDER SHALL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY.
IN WITNESS WHEREOF, Borrowers and Lender have caused this Agreement to be executed by their respective duly authorized officers as of the date first above written.
|
|
BORROWERS:
|
|
|
ATRION CORPORATION,
a Delaware corporation
|
|
By: /s/ Xxxxxxx Xxxxxxxxxx
|
|
|
Xxxxxxx Xxxxxxxxxx
|
|
|
Its Vice President
|
|
|
ATRION MEDICAL PRODUCTS, INC.,
|
|
|
an Alabama corporation
|
|
|
By: /s/ Xxxxxxx Xxxxxxxxxx
|
|
|
Xxxxxxx Xxxxxxxxxx
|
|
|
Its Vice President
|
|
XXXXXX-XXXXXXX CORPORATION,
a Florida corporation
|
|
|
By: /s/ Xxxxxxx Xxxxxxxxxx
|
|
|
Xxxxxxx Xxxxxxxxxx
|
|
|
Its Vice President
|
|
|
QUEST MEDICAL, INC.,
a Texas corporation
|
|
|
By: /s/ Xxxxxxx Xxxxxxxxxx
|
|
|
Xxxxxxx Xxxxxxxxxx
|
|
|
Its Vice President
|
|
ALATENN PIPELINE COMPANY, LLC,
an Alabama limited liability company
|
|
|
By: /s/ Xxxxxxx Xxxxxxxxxx
|
|
|
Xxxxxxx Xxxxxxxxxx
|
|
|
Its Vice President
|
|
ATRION LEASING COMPANY, LLC,
an Alabama limited liability company
|
|
|
By: /s/ Xxxxxxx Xxxxxxxxxx
|
|
|
Xxxxxxx Xxxxxxxxxx
|
|
|
Its Vice President
|
|
LENDER:
|
|
|
WACHOVIA BANK, NATIONAL ASSOCIATION,
a national banking association
|
|
|
By: /s/ Xxxxx Xxxxxx
|
|
|
Xxxxx Xxxxxx
|
|
|
Senior Vice President
|
REVISED EXHIBIT A
PRICING MATRIX
(Effective July _1__, 2008)
|
If the ratio of Consolidated
|
The Line of Credit
|
The Unused Line
|
The Term Loan
|
|
Total Liabilities/Consolidated
|
Loan Margin
|
Fee Will Be:
|
Margin Will Be:
|
|
Tangible Net Worth is:
|
Will Be:
|
||
|
Greater than 2.00
|
200 bps (2.00%)
|
50 bps (.50%)
|
225 bps (2.25%)
|
|
1.51 to 2.00
|
150 bps (1.50%)
|
50 bps (.50%)
|
175 bps (1.75%)
|
|
1.15 to 1.50
|
125 bps (1.25%)
|
25 bps (.25%)
|
150 bps (1.50%)
|
|
Less than 1.15
|
100 bps (1.00%)
|
7.5 bps (.075%)
|
125 bps (1.25%)
|
